
Tim Hortons Smile Cookie campaign in Burlington a key fundraiser for food bank
Restructuring of Burlington Food Bank and FeedHalton will create a stronger focus for both organizations, as the food bank enters one of its most important fundraising events of the year.
The annual Smile Cookie campaign, which sees money raised from sale of the happy face treats at 11 Burlington Tim Hortons locations,
runs April 28 to May 4
.
Krista Kay, director of marketing and community fundraising for both the local food bank and FeedHalton, said Tim Hortons' launch of the event benefitting the food bank might be overshadowed by the federal election being on the same day.
Kay suggested voters could reward themselves with a Smile Cookie after casting a ballot.
She said the event that raised approximately $145,000 for the food bank each of the past two years is key at a time of year when community food donations are down.
Last year, the campaign fell short of a $175,000 goal — at least partly because one Burlington Tim Hortons was closed at the time. The
2201 Brant St. location is back
for this year's Smile Cookie campaign.
'The stores here have been amazing supporters of the food bank,' Kay said. 'The store owners put a ton of effort in.'
She figures about $150,000 is an achievable goal as $2 cookie sales across the city add up.
Kay said there's plenty of local good news during the annual campaigns, including a local father who buys 300 cookies for his child's school each year.
Just before Smile Cookie sales kick off, Burlington Food Bank is celebrating its staff and volunteers with an invite-only event at the Art Gallery of Burlington May 23.
Robin Bailey, executive director of both the local food bank and FeedHalton, is leaving Burlington Food Bank to focus on the FeedHalton position.
Current food bank manager Christina Mulder will take on the new role of Burlington Food Bank director.
Kay said FeedHalton was formed in 2023, sharing staff and a board of directors with the local food bank.
FeedHalton has since obtained its own charitable designation and two separate staffs and boards are being formed for the two organizations.
FeedHalton's website
states the organization formed to help manage growing food insecurity regionwide. It 'provides centralized resources and physical warehousing for procurement, storing, sorting and distribution of perishable and non-perishable food and essential goods to local community organizations.'
Maria Thornton is leaving the food bank board chair position to focus on chairing FeedHalton's board. Burlington Food Bank board member Rick Owens will take over as food bank chair.
Kay said Bailey helped grow Burlington Food Bank's capacity, and steered it through COVID-19 — introducing a delivery model when people couldn't go in the food bank. Bailey served as food bank executive director for seven years.
'This event is largely in recognition of (Bailey's) contributions to food security in Burlington and the food bank,' Kay said.
Visit
Burlington Food Bank's website
for more information.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
42 minutes ago
- Newsweek
Former Labor Secretary: Here's How Trump Should Rebuild American Manufacturing
Advocates for ideas and draws conclusions based on the interpretation of facts and data. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The House of Representatives recently held a hearing that explored strengthening American manufacturing, specifically in the medical space. The congressional inquiry echoed President Donald Trump's "Made in America" agenda, which intends to ramp up domestic production of everything from cars and trucks to iPhones and computer chips. But as this new landscape takes shape, returning to "peak" American manufacturing should not necessarily be the goal. The world looks very different today than it did in the 1970s, and so does our labor force. Policymakers should focus on making targeted investments—driven by smart tax incentives and reduced regulatory barriers—in key sectors that will help the country meet the strategic demands of the 21st century. President Trump has made it clear he will provide incentives to American companies willing to reshore operations closer to home. But two sectors in particular—national defense and health care—require the most attention. That's because both are foundational to the country's long-term stability and resilience, yet remain concerningly reliant on foreign supply chains that are vulnerable to disruption and manipulation. Take semiconductors. These chips power everything from smartphones to fighter jets, yet the vast majority of production occurs overseas in places like Taiwan. With COVID-19's supply chain disruptions fresh in our memory and China's growing hostility toward Taiwan, America should not be dependent on troubled areas for the technologies that underpin our defense systems. The same applies to shipbuilding and aerospace. In April, President Trump signed an executive order to restore American maritime dominance by boosting domestic vessel production. The initiative not only reinforces our national defense infrastructure; it also presents a major opportunity to revitalize America's skilled labor force by bringing thousands of high-quality manufacturing and engineering jobs back to coastal and heartland communities alike. US President Donald Trump (L) gestures as US Labor Secretary Alexander Acosta looks on as they speak to the media on July 12, 2019 at the White House in Washington, DC. US President Donald Trump (L) gestures as US Labor Secretary Alexander Acosta looks on as they speak to the media on July 12, 2019 at the White House in Washington, DC. Alastair Pike / AFP/Getty Images Such a large-scale effort would rely on smaller manufacturers to supply key components and materials. Large manufacturers currently take up that spotlight. (The recent deal brokered between U.S. Steel and Nippon Steel is a prime example.) But for every large manufacturer willing to take part in the "Made in America" campaign, ten smaller manufacturers are lining up at the door. Connecting small manufacturers to procurement pipelines—and reducing the regulatory burdens they face—would unleash a new level of innovation and coordination across the country. Just as national defense requires a robust industrial foundation, so too does our health care system. In fact, a strong health care system is itself essential to protecting and defending the nation. The inevitable vulnerabilities of diversified global supply chains, coupled with China's focused efforts to invest in its own biomedical industries, leaves Americans exposed when diplomatic relationships sour or global crises strike. Fortunately, the U.S. already has the infrastructure to bring pharmaceutical manufacturing home. States like Indiana, North Carolina, Ohio, and Pennsylvania are established industry hubs. Meanwhile, the U.S. territory of Puerto Rico—which currently boasts the second-largest pharmaceutical manufacturing output in the country—has long supported large-scale medicine production and is poised to continue to do so. Incentivizing further investment in these areas must remain a top priority for the Trump administration. The White House's recent executive action to reduce regulatory barriers for pharmaceutical companies reshoring their operations is a strong start—but it shouldn't stand alone. The budget reconciliation package, now advancing in Congress, presents a key opportunity to pair these efforts with targeted, pro-growth tax incentives. Cutting government red tape and lowering taxes can lay the foundation for a new golden age of American manufacturing. Rebuilding American manufacturing, an idea with strong national support, is rightly a focus of President Trump and his allies in Congress. But rather than spreading resources thin to cast a wide net that lightly lifts production across the board, policymakers should focus their energy on restoring the production capacity of sectors critical to national security and Americans' health. Alexander Acosta served as the 27th United States Secretary of Labor from 2017 to 2019. The views expressed in this article are the writer's own.


Newsweek
an hour ago
- Newsweek
Housing Market Warning Issued: 'No One Is Buying New Homes'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Demand for new homes dropped to its lowest level in nearly three years last month, according to the latest data, as builders across the country brace for a significant slowdown in construction in the coming months. "No one is buying new homes that are under construction or permitted," Nick Gerli, a real-estate analyst and CEO of Reventure App, wrote on X, formerly Twitter. "Months of supply for both is sitting between 15-20 months, which is basically the highest on record." Months of supply refers to the number of months it would take to go through all listings available on the market at the current pace of sales. That means that buyers would go through the current levels of new home inventory in the U.S. market in 15 to 20 months—much longer than what is considered necessary for a balanced market, about six months. Builders have already taken notice of the growing sluggishness in the new homes market and are losing the motivation to start new projects, as shown by recent data which found that new U.S. residential construction fell to its slowest pace since the outbreak of the COVID-19 pandemic. Rising Inventory and Tumbling Sales For years after the subprime mortgage crisis of 2007-2008, the U.S. massively underbuilt compared to demand, leaving the country with a severe lack of supply. This housing shortage, which continues to this day, contributed to the massive surge in prices during the pandemic homebuying frenzy spurred by historically low mortgage rates. In the last few years, however, construction projects have picked up across the country, especially in states like Florida and Texas, which experienced a boom in demand since the outbreak of the pandemic. New housing inventory is now at its highest level since late 2007, marking a positive step forward out of the shortage that has characterized the market since the Great Recession. Houses undergo construction in a neighborhood on April 17, 2025, in Austin, Texas. Houses undergo construction in a neighborhood on April 17, 2025, in Austin, sales of new homes are falling, as buyers continue struggling with sky-high prices and elevated mortgage rates. As of June 26, the average 30-year fixed-rate mortgage was 6.77 percent, according to Freddie Mac, nearly three times the lows reported during the pandemic. In May, new home sales dropped by 13.7 percent compared to a month earlier, to a seasonally adjusted annualized rate of 623,000 units, according to the Commerce Department's Census Bureau. It was the biggest monthly drop since June 2022 and a much larger than expected decline, even considering that demand in the overall housing market is cooling all across the country. Compared to a year earlier, new home sales were down by 6.3 percent. "Taken together, increases in inventory and months supply, mirror the trend of softening demand in the existing home sale market," senior economist Jake Krimmel said in a statement shared with Newsweek. "Whether the new and existing home sale markets continue to move in tandem will be something to watch going forward this summer." According to Reventure App data, months of supply for homes permitted, but not started, is "literally the highest level on record," Gerli said, at 19.4 months, "meaning basically no one right now is willing to enter into a sales contract for a home to be built," he added. "That says a lot about the current state of demand." Homes under construction, by comparison, have a months supply of 14.8 months—the second-highest level on record behind 2008—while completed homes have a rather competitive supply of 3.6 months. "There were 30,000 new home sales for completed products in May 2025, which was basically close to the highest level on record, meaning builders are able to move the completed inventory," Gerli said. "But there's still a ton of completed inventory hitting the market, because the pipeline of homes under construction is so big," he added. "Right now, there are 268,000 homes for sale under construction. That's a 2007-08 level of supply." Builders Are Losing Motivation U.S. builders are wary of the slowdown in demand across the country and the rise in construction material prices caused by President Donald Trump's tariffs, and are losing motivation to build new homes. According to the most recent survey conducted by the National Association of Home Builders (NAHB), sentiment among U.S. homebuilders is now at its lowest level since 2022, as many are forced to cut prices and offer incentives to entice reluctant buyers. The survey found that the share of homebuilders lowering prices in June has climbed to 37 percent—the highest reported by NAHB since 2022. Negativity is spreading among builders and is reflected in the falling numbers of new home-building permits and homes under constructions. Housing starts dropped by 9.8 percent to an annualized rate of 1.26 million homes in May, according to the latest government figures. Multifamily starts fell by nearly 30 percent, while new single-family home construction climbed to a 924,000 rate. The number of building permits issued last month also declined to an annualized rate of 1.39 million, marking a five-year low. Permits for the construction of single-family homes fell to their slowest pace since April 2023. What Does This Mean for the Housing Market? Home construction is expected to continue stalling as costs rise for both builders and buyers, meaning that the U.S. will not get out of its housing shortage anytime soon and Americans will continue facing historically high prices. "Builders face higher financing costs, tariff uncertainty, softer demand from elevated rates, increased competition from rising existing-home inventory in key markets like Texas and Florida, and higher inventories of their own," Odeta Kushi, deputy chief economist at First American, told Real Estate News. "This mix is weighing on builder sentiment." According to Robert Dietz, chief economist at NAHB, "builders will be pulling back on construction in the months ahead" due to the current levels of inventory, he told
Yahoo
5 hours ago
- Yahoo
Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 26, William Blair reaffirmed its 'Market Perform' rating for Maravai stock. The key factor influencing this move is the leadership changes at Maravai. A scientist performing a blood test on a patient using life sciences tools & services. Maravai has undergone a complete leadership overhaul since December last year. In December 2024, the company brought in Andy Eckert as the new independent Chairman of the Board. Later, Maravai installed Bernd Brust as CEO, replacing Trey Martin. Then, on June 25, a new press release indicated that Rajesh 'Raj' Asarpota would assume the position of Executive Vice President and Chief Financial Officer, effective June 30. According to William Blair, Brust and Asarpota are joining Maravai's top-level management when the company is undergoing 'a challenging operational transition period.' The analysts noted that the company 'faces approximately $66 million in headwinds in 2025 from declining COVID-related revenues.' As such, the analysts are optimistic that the fresh hands at Maravai's helm will inject more momentum into the transition. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is a life sciences company. It provides specialized products that support the development of vaccines, drug therapies, diagnostics, and cell and gene therapies. Its operations span two segments: Nucleic Acid Production and Biologics Safety Testing. While we acknowledge the potential of MRVI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Energy Stocks: 10 Stocks to Buy and 10 Best AI Stocks to Buy According to Billionaire David Tepper. Disclosure: None.